Abstract Details
Syed M. Jafri
PRESENTER |
Mr. Jafri has nothing to disclose. |
Rachel Thompson | Miss Thompson has nothing to disclose. |
Muhannad Seyam, MD | Dr. Seyam has nothing to disclose. |
Joan Skelly (University of Vermont) | Joan Skelly has nothing to disclose. |
Margo Nolan, BA | Miss Nolan has nothing to disclose. |
Jiayi Luo | Ms. Luo has nothing to disclose. |
Waqar Waheed, MD, MBBS | Dr. Waheed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. |
Edward J. Kasarskis, MD, PhD, FAAN (UK Healthcare) | The institution of Dr. Kasarskis has received research support from Healey Platform Trial Group. The institution of Dr. Kasarskis has received research support from Amylyx . The institution of Dr. Kasarskis has received research support from Alexion. The institution of Dr. Kasarskis has received research support from Woolsey . Dr. Kasarskis has a non-compensated relationship as a Director of ALSA-supported clinic at the University of Kentucky with ALS Association that is relevant to AAN interests or activities. |
Rup Tandan, MD, FRCP, FAAN (University of Vermont (UVM)/UVM Medical Center) | Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics. |